Jefferies Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $7.93M | Hold |
181,200
| – | – | 0.07% | 244 |
|
|
2022
Q2 | $9.5M | Buy |
181,200
+156,000
| +619% | +$7.95M | 0.08% | 201 |
|
|
2022
Q1 | $1.3M | Sell |
25,200
-497,800
| -95% | -$25.8M | 0.01% | 822 |
|
|
2021
Q4 | $30.9M | Sell |
523,000
-327,000
| -38% | -$16.2M | 0.18% | 88 |
|
|
2021
Q3 | $36.6M | Buy |
850,000
+793,900
| +1,415% | +$35.2M | 0.27% | 56 |
|
|
2021
Q2 | $2.2M | Buy |
+56,100
| New | +$2.18M | 0.01% | 722 |
|
|
2021
Q1 | – | Sell |
-164,100
| Closed | -$6.04M | – | 1900 |
|
|
2020
Q4 | $6.04M | Sell |
164,100
-398,736
| -71% | -$14.6M | 0.05% | 350 |
|
|
2020
Q3 | $19.6M | Buy |
562,836
+404,314
| +255% | +$14.2M | 0.22% | 60 |
|
|
2020
Q2 | $4.92K | Sell |
158,522
-34,255
| -18% | -$1.16M | 0.06% | 278 |
|
|
2020
Q1 | $5.97M | Sell |
192,777
-189,825
| -50% | -$6.47M | 0.07% | 263 |
|
|
2019
Q4 | $14.2M | Sell |
382,602
-343,288
| -47% | -$12.2M | 0.11% | 160 |
|
|
2019
Q3 | $24.7M | Buy |
725,890
+230,932
| +47% | +$8.4M | 0.19% | 65 |
|
|
2019
Q2 | $20.3M | Buy |
494,958
+203,316
| +70% | +$8.07M | 0.15% | 98 |
|
|
2019
Q1 | $11.8M | Sell |
291,642
-32,358
| -10% | -$1.3M | 0.1% | 173 |
|
|
2018
Q4 | $13.4M | Sell |
324,000
-1,212,416
| -79% | -$50.3M | 0.11% | 140 |
|
|
2018
Q3 | $64.2M | Buy |
1,536,416
+1,416,365
| +1,180% | +$54.5M | 0.42% | 26 |
|
|
2018
Q2 | $4.13M | Sell |
120,051
-924,463
| -89% | -$31.6M | 0.02% | 568 |
|
|
2018
Q1 | $35.2M | Buy |
1,044,514
+741,700
| +245% | +$25.5M | 0.19% | 61 |
|
|
2017
Q4 | $10.4M | Sell |
302,814
-306,293
| -50% | -$10.4M | 0.05% | 300 |
|
|
2017
Q3 | $20.6M | Buy |
609,107
+15,389
| +3% | +$495K | 0.14% | 117 |
|
|
2017
Q2 | $18.9M | Sell |
593,718
-144,082
| -20% | -$4.54M | 0.13% | 137 |
|
|
2017
Q1 | $23.9M | Sell |
737,800
-2,809,121
| -79% | -$88.6M | 0.18% | 89 |
|
|
2016
Q4 | $109M | Sell |
3,546,921
-287,953
| -8% | -$8.79M | 0.61% | 17 |
|
|
2016
Q3 | $123M | Buy |
3,834,874
+316,833
| +9% | +$10.6M | 0.64% | 19 |
|
|
2016
Q2 | $118M | Sell |
3,518,041
-965,991
| -22% | -$30.8M | 0.53% | 20 |
|
|
2016
Q1 | $126M | Buy |
4,484,032
+918,245
| +26% | +$26.2M | 0.73% | 13 |
|
|
2015
Q4 | $109M | Buy |
3,565,787
+2,009,872
| +129% | +$63.2M | 0.62% | 23 |
|
|
2015
Q3 | $46.4M | Buy |
1,555,915
+1,276,500
| +457% | +$40.9M | 0.27% | 66 |
|
|
2015
Q2 | $8.89M | Sell |
279,415
-95,598
| -25% | -$3.12M | 0.05% | 330 |
|
|
2015
Q1 | $12.4M | Sell |
375,013
-394,407
| -51% | -$12.5M | 0.07% | 196 |
|
|
2014
Q4 | $22.7M | Buy |
769,420
+453,220
| +143% | +$13M | 0.13% | 129 |
|
|
2014
Q3 | $8.87M | Hold |
316,200
| – | – | 0.06% | 267 |
|
|
2014
Q2 | $8.9M | Buy |
316,200
+158,838
| +101% | +$4.53M | 0.08% | 236 |
|
|
2014
Q1 | $4.8M | Buy |
+157,362
| New | +$4.69M | 0.05% | 318 |
|
|
2013
Q3 | – | Sell |
-1,328,567
| Closed | -$35.3M | – | 2135 |
|
|
2013
Q2 | $35.3M | Buy |
+1,328,567
| New | +$36.7M | 0.38% | 33 |
|
Other funds holding PFE
Jefferies Group's PFE Position: Q3 2022 in Review
Jefferies Group increased its Pfizer (PFE) stake by 45% in Q3 2022, buying an estimated $3.42M and bringing the position to 224,984 shares worth $9.85M. The position accounts for 0.08% of the portfolio, ranked #192.
Jefferies Group first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $56.6M in Q4 2015. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Jefferies Group held 224,984 shares of Pfizer worth $9.85M as of Q3 2022.
- Jefferies Group bought 70,327 Pfizer shares in Q3 2022, an estimated $3.42M.
- Pfizer made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #192 holding.
- Jefferies Group first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Jefferies Group's Pfizer position peaked at $56.6M in Q4 2015.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.